Tate & Lyle AI Stock Analysis
Want to see TATYY full AI Analyst Report?
Tate & Lyle (TATYY) AI Stock Analysis
Tate & Lyle
(Other OTC:TATYY)
The score is supported most by positive earnings-call execution and moderately favorable technical positioning. These strengths are tempered by declining profitability and returns, increased leverage, volatile cash conversion, and a relatively full P/E valuation.
Tate & Lyle (TATYY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $6.99B
- Dividend Yield
- 3.50%
- Average Volume (3M)
- 268
- Price to Earnings (P/E)
- 25.3
- Beta (1Y)
- 0.50
- Revenue Growth
- 21.44%
- EPS Growth
- 48.65%
- Country
- US
- Employees
- 4,840
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Packaged Foods
Tate & Lyle Business Overview & Revenue Model
Company Description
Tate & Lyle PLC, along with its subsidiaries, offers a diverse portfolio of ingredients and specialized solutions catering to the food, beverage, and other industrial sectors. Its global footprint spans the United States, the United Kingdom, continen...
How the Company Makes Money
Tate & Lyle makes money primarily by manufacturing and selling specialty food and beverage ingredients to business customers (B2B), especially large and mid-sized packaged food, beverage, and consumer health/nutrition product manufacturers. Revenue i...
Tate & Lyle Earnings Call Summary
The call was predominantly positive. Tate & Lyle reported a return to volume-led growth, strong cash generation, continued pipeline and fiber momentum, an on-track bio-gums project, progress on the Ingredion transaction, and maintained full-year guidance. These positives were tempered by a challenging European consumer environment, muted North American consumer demand, prolonged Middle East-related pressures, and a tougher and volatile cost and contracting environment.
Q2-2027 Updates
Positive Updates
Negative Updates
Company Guidance
Tate & Lyle is maintaining its outlook for the full year ending 31st of March 2027; H2 versus H1 is not expected to involve “a significant step-up,” with the full-year outcome dependent on developments in calendar year ’27, while the company intends to pass through cost inflation through 2027 calendar year framework agreements and seek to offset it through procurement activities and operational discipline. The bio-gum consolidation project is “proceeding as we anticipated and is on track,” fiber is expected to accelerate and continue growing through the next 12 to 18 months, and completion of the Ingredion transaction is still expected in the second half of calendar year 2027.
Tate & Lyle Financial Statement Overview
Summary
Revenue growth, solid gross profitability, positive cash flow, and improved 2026 free cash flow are offset by declining operating and net margins, higher leverage, lower returns on equity, and volatile cash generation.
Income Statement
63PositiveBalance Sheet
57NeutralCash Flow
61Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.00B | 2.01B | 1.74B | 1.65B | 1.75B | 1.38B |
| Gross Profit | -105.00M | 919.00M | 706.00M | 851.00M | 733.00M | 514.00M |
| EBITDA | 412.22M | 413.00M | 254.00M | 345.00M | 279.00M | 168.00M |
| Net Income | 97.00M | 97.00M | 143.00M | 188.00M | 190.00M | 236.00M |
Balance Sheet | ||||||
| Total Assets | 3.67B | 3.67B | 3.73B | 2.28B | 2.51B | 3.25B |
| Cash, Cash Equivalents and Short-Term Investments | 344.02M | 344.02M | 334.00M | 437.00M | 475.00M | 112.00M |
| Total Debt | 1.29B | 1.29B | 1.31B | 590.00M | 713.00M | 679.00M |
| Total Liabilities | 2.07B | 2.07B | 2.14B | 1.04B | 1.32B | 1.63B |
| Stockholders Equity | 1.60B | 1.60B | 1.59B | 1.24B | 1.19B | 1.62B |
Cash Flow | ||||||
| Free Cash Flow | 122.44M | 123.98M | 43.00M | 98.00M | -12.00M | -45.00M |
| Operating Cash Flow | 239.20M | 241.87M | 164.00M | 208.00M | 66.00M | 103.00M |
| Investing Cash Flow | -121.89M | -122.97M | -630.00M | -20.00M | 835.00M | -113.00M |
| Financing Cash Flow | -106.39M | -107.72M | 367.00M | -215.00M | -598.00M | -247.00M |
Tate & Lyle Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TATYY, the sentiment is Negative. The current price of 29.67 is below the 20-day moving average (MA) of 30.09, below the 50-day MA of 29.93, and above the 200-day MA of 25.78, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 40.53 is Neutral, neither overbought nor oversold. The STOCH value of -0.06 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TATYY.
Tate & Lyle Peers Comparison
Overall Rating
DAR76Outperform
MZTI74Outperform
SENEA74Outperform
TATYY64Neutral
INGR63Neutral
WEST54Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | $8.67B | 10.46 | 16.72% | ― | 15.79% | 687.52% | |
| 74Outperform | $3.02B | 17.48 | 16.83% | 3.60% | -0.94% | 2.86% | |
| 74Outperform | $1.18B | 10.11 | 15.60% | ― | 12.06% | 100.55% | |
| 64Neutral | $3.28B | 25.27 | 6.12% | 3.50% | 21.44% | 48.65% | |
| 63Neutral | $5.86B | 10.59 | 12.58% | 3.49% | -0.98% | -12.90% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 54Neutral | $834.62M | -14.89 | -21.74% | ― | 16.29% | 42.55% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TATYY | Tate & Lyle Plc Sponsored Adr | 29.67 | 10.55 | 55.15% | |
| DAR | Darling Ingredients | 55.99 | 20.94 | 59.74% | |
| MZTI | Marzetti Company | 110.97 | -54.02 | -32.74% | |
| SENEA | Seneca Foods | 176.47 | 50.69 | 40.30% | |
| INGR | Ingredion | 94.14 | -9.86 | -9.48% | |
| WEST | Westrock Coffee Company | 8.34 | 4.08 | 95.77% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
